Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)
Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)
Active, not recruiting · NCT06189742 · Registry updated 2026-01-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS) | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis | Active, not recruiting | Phase 2 | 2026-01-20 | NCT06189742 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dr. Anne Ellis | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kingston Health Sciences Centre- Kingston General Hospital | Kingston | Canada | 1 |